Insufficient scRNA-seq data for expression of BFSP1 at single-cell level.
Insufficient scRNA-seq data for expression of BFSP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 134.09 | 240 / 245 | 94% | 2.05 | 471 / 502 |
bladder | 100% | 141.43 | 21 / 21 | 91% | 3.27 | 459 / 504 |
breast | 96% | 119.98 | 440 / 459 | 93% | 4.03 | 1045 / 1118 |
skin | 96% | 94.42 | 1729 / 1809 | 94% | 10.53 | 442 / 472 |
pancreas | 96% | 111.61 | 316 / 328 | 92% | 2.68 | 164 / 178 |
uterus | 100% | 205.24 | 170 / 170 | 87% | 3.33 | 401 / 459 |
lung | 96% | 155.73 | 556 / 578 | 88% | 3.55 | 1020 / 1155 |
thymus | 100% | 278.60 | 651 / 653 | 84% | 3.92 | 511 / 605 |
esophagus | 99% | 184.72 | 1430 / 1445 | 80% | 2.84 | 147 / 183 |
intestine | 90% | 104.39 | 872 / 966 | 86% | 2.88 | 453 / 527 |
stomach | 84% | 75.86 | 301 / 359 | 78% | 2.13 | 223 / 286 |
kidney | 97% | 152.28 | 86 / 89 | 63% | 1.81 | 566 / 901 |
ovary | 100% | 156.04 | 180 / 180 | 47% | 1.16 | 204 / 430 |
adrenal gland | 97% | 133.32 | 251 / 258 | 43% | 1.15 | 99 / 230 |
brain | 99% | 231.31 | 2614 / 2642 | 37% | 0.81 | 262 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.59 | 1 / 1 |
blood vessel | 99% | 222.08 | 1317 / 1335 | 0% | 0 | 0 / 0 |
adipose | 96% | 110.25 | 1151 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 2.71 | 65 / 80 |
tonsil | 0% | 0 | 0 / 0 | 78% | 2.57 | 35 / 45 |
spleen | 70% | 43.28 | 169 / 241 | 0% | 0 | 0 / 0 |
heart | 59% | 36.64 | 504 / 861 | 0% | 0 | 0 / 0 |
liver | 15% | 6.78 | 34 / 226 | 40% | 0.94 | 164 / 406 |
peripheral blood | 29% | 23.20 | 266 / 929 | 0% | 0 | 0 / 0 |
muscle | 15% | 7.30 | 122 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.12 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045109 | Biological process | intermediate filament organization |
GO_0048469 | Biological process | cell maturation |
GO_0070307 | Biological process | lens fiber cell development |
GO_0008150 | Biological process | biological_process |
GO_0005938 | Cellular component | cell cortex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005882 | Cellular component | intermediate filament |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0005515 | Molecular function | protein binding |
GO_0005212 | Molecular function | structural constituent of eye lens |
Gene name | BFSP1 |
Protein name | Filensin (Beaded filament structural protein 1) (Lens fiber cell beaded-filament structural protein CP 115) (CP115) (Lens intermediate filament-like heavy) (LIFL-H) [Cleaved into: Filensin C-terminal fragment; Filensin N-terminal fragment] |
Synonyms | |
Description | FUNCTION: Required for the correct formation of lens intermediate filaments as part of a complex composed of BFSP1, BFSP2 and CRYAA . Involved in altering the calcium regulation of MIP water permeability . . |
Accessions | ENST00000536626.7 [Q12934-3] ENST00000377873.8 [Q12934-1] ENST00000377868.6 [Q12934-2] Q12934 |